Skip to main content
. 2013 Feb 1;14(2):95–99. doi: 10.4161/cbt.22960

graphic file with name cbt-14-95-g2.jpg

Figure 2. Dose responses of Ki-CA patient derived cell line to selected drugs. Cells were added to 96-well plates containing each small-molecule inhibitor at 11 serial dilutions spanning a concentration range that includes the predicted IC50 and evaluated as in Figure 1. Values shown are mean ± SD for triplicate wells. Best fit curves were generated using GraphPad Prism software.

HHS Vulnerability Disclosure